Premium
Nutritional supplements in age‐related macular degeneration
Author(s) -
Schmidl Doreen,
Garhöfer Gerhard,
Schmetterer Leopold
Publication year - 2015
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.12650
Subject(s) - macular degeneration , medicine , blindness , micronutrient , disease , regimen , intensive care medicine , degeneration (medical) , ophthalmology , surgery , optometry , pathology
Age‐related macular degeneration ( AMD ) is the most frequent cause of blindness in the W estern W orld. While with new therapies that are directed towards vascular endothelial growth factor ( VEGF ), a potentially efficient treatment option for the wet form of the disease has been introduced, a therapeutic regimen for dry AMD is still lacking. There is evidence from several studies that oral intake of supplements is beneficial in preventing progression of the disease. Several formulations of micronutrients are currently available. The present review focuses on the role of supplements in the treatment and prevention of AMD and sums up the current knowledge about the most frequently used micronutrients. In addition, regulatory issues are discussed, and future directions for the role of supplementation in AMD are highlighted.